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Intensity of speech-language therapy (SLT) is an important component of any aphasia 
intervention. Studies have indicated that the more intense and frequent the speech-
language treatment, the better the outcome. Intensive SLT has been associated with 
significant improvements (Pulvermuller et al., 2001; Meinzer et al, 2005). Additional 
support for more intensive SLT was demonstrated in a retrospective analysis of 10 
studies investigating aphasia therapy after stroke (Bhogal et al., 2003). Five studies with a 
significant treatment effect provided an average of 8.8 hours (5-10) of treatment per week 
for an average of 11.2 weeks (8-12). Five negative studies provided only about 2 hours 
(2-3.8) of SLT per week for 22.9 weeks (20-26). These findings are consistent with those 
of  Robey (1998), who, in a meta-analysis of clinical outcomes in aphasia treatment, also 
revealed that the more intensive the therapy the greater the improvement. While the 
evidence certainly suggests that intense SLT over a shorter amount of time is more 
beneficial, no well-designed prospective randomized clinical trial has directly addressed 
this question.  
 
The purpose of this study is to compare high-intensity (10-hours per week) versus low-
intensity (4-hours per week) aphasia treatment. However, intensive therapy is costly. An 
effective and economical option for delivering SLT at high intensity is via computer. 
Therefore, for this study, a computer version of an aphasia treatment technique that has 
previously been shown as efficacious when delivered by a speech-language pathologist, 
was developed.   
 
More specifically, the purpose of this randomized single-blind study was to: 
1) assess the efficacy of a treatment, Oral Reading for Language in Aphasia (ORLA), 
when provided via computer 
2) evaluate the effects of treatment intensity by comparing high-intensity versus low-
intensity Computer ORLA (C-ORLA) 
 
METHODS 
 
Subjects:   
Forty-seven individuals with nonfluent aphasia following a single left-hemisphere 
ischemic stroke occurring more than 6 months previously participated. No subjects 
presented clinically with global aphasia. All subjects were right handed, with at least a 
12th grade education.   
 
Subjects comprised three groups.  Twenty-two subjects were recruited prospectively and 
randomized into either 4-hours or 10-hours of C-ORLA treatment per week.  Twenty-five 
subjects who had participated in a previous study served as no-treatment controls.  Table 
1 shows demographic data for the three groups of subjects. Groups were equivalent on 
age, months post onset, and severity of aphasia as determined by the Aphasia Quotient of 
the Western Aphasia Battery. 
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Treatment: 
 
Oral Reading for Language in Aphasia (ORLA) is a technique in which the person with 
aphasia repeatedly reads aloud sentences and paragraphs, first in unison with the 
clinician, and then independently. ORLA focuses on connected discourse rather than 
single words, permitting the modeling of more natural rhythm and intonations. It also 
allows practice on a variety of grammatical structures, rather than just one specific 
grammatical form. Consistent with a stimulation approach, ORLA uses repetitive 
multimodality stimulation to elicit a response. It is also consistent with principles of 
learning theory (active participation by the learner, repetitive practice in the overlearning 
of skills, use of meaningful materials that are graded in difficulty).   
 
C-ORLA is a computer version of ORLA. Using state-of-the-art computer technology,   
the program has an animated agent that serves as a virtual therapist. The animated agent 
produces natural speech with correct movements of the speech articulators, repeatedly 
reading aloud with the patient, in exactly the same way as a therapist would administer 
ORLA. Figure 1 shows examples of patient interface screens. 
 
For the prospective group, patients were assessed pre-treatment, then randomized to 
either the 4-hour or 10-hour group. Subjects were trained on C-ORLA and laptops 
containing the program were loaned to them. Treatment lasted 6 weeks  patients.  
practiced at home independently, returning to see the speech-language pathologist once 
per week to ensure that practice was done correctly. Mechanisms to ensure compliance 
were developed. Log on and log off times were time stamped on the computer and lists of 
all stimuli that were practiced were generated and stored. In addition, subjects were asked 
to complete practice logs.  
 
Subjects were reassessed immediately post-treatment. Additionally, for subjects 
randomized to the 10-hour group, an interim test session was scheduled following 24 
hours of treatment, that is the same number of treatment sessions that the 4-hour group 
received after 6 weeks of treatment.   
 
Outcomes.  Speech and language recovery was measured with the Western Aphasia 
Battery  Aphasia Quotient (WAB-AQ). For the 4-hour treatment group, WAB AQ 
assessment occurred at baseline and following 6-weeks of treatment (after 24 treatment 
hours). For the 10-hour treatment group, WAB AQ assessment occurred at baseline, after 
24 treatment hours, and following 6-weeks of treatment (after 60 treatment hours). The 
no-treatment control subjects were evaluated 6-weeks apart. 
 
RESULTS 
 
An intent-to-treat analysis was conducted on the data i.e. analyses were based on the 
group to which subjects were randomized.  
   
Group data  
1. The mean change in WAB AQ for all 22 C-ORLA subjects was 5.21 (SD= 6.88).  
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The mean change in WAB AQ for the 25 no-treatment control subjects was -0.86 
(SD=3.54). The difference in WAB AQ change scores between treatment and 
control groups was significant (p<.01). See Figure 2. 
2. Following 6-weeks of treatment, the mean change in WAB AQ score was 6.76 
(SD=7.63) for the 10 hour group and 3.92 (std deviation 6.22) for the 4 hour 
group. The difference in WAB AQ change scores between the 4-hour and 10-hour 
treatment groups was not significant (p>.05). 
3. Following 24 treatment sessions, the mean change in WAB AQ  from pre-
treatment to interim testing (i.e. after 24 sessions distributed over 2.5 weeks) in 
the 10-hour group was 1.66 (SD=4.94). This was not significantly different from 
the change made by the 4-hour treatment group after 24 sessions distributed over 
6 weeks. 
 
Individual subject data 
For the 10-hour group, changes in WAB AQ scores ranged from -1.4 to 22.2 points, with 
6 of 10 subjects improving more than 5 points. Amount of change was correlated with 
pre-treatment WAB AQ score (r=0.61), indicating that the more severe the aphasia, the 
greater the improvement. For the 4-hour group, changes in WAB AQ scores ranged from 
-3.40 to 15.5, with 4 of 12 subjects improving more than 5 points. There was no 
correlation between amount of change and initial severity based on pre-treatment WAB 
scores (r=0.01). 
 
DISCUSSION AND CONCLUSIONS 
 
C-ORLA may be an efficacious treatment for people with chronic nonfluent aphasia. 
Over the 6-week period, there was a trend for greater language improvement with 
increased intensity and amount of therapy. This was not unexpected since the 10-hour 
group received more treatment hours than the 4-hour groups.  However, after 24 
treatment hours for both the 4-hour and 10-hour groups, there was a trend towards greater 
improvement when sessions were scheduled less intensively. Thus there may be a critical 
amount and intensity of treatment that is required for maximum improvement. Different 
intensities of treatment may be preferable at different times during the learning process.  
 
This study represents one of the largest randomized clinical trials in aphasia treatment to 
date. The study used an intent-to-treat analysis which is the recognized analysis to use in 
clinical trials.  However, data was also analyzed from group assignment based on actual 
participant behaviors. These differences and the appropriateness of the intent-to-treat 
analysis for future aphasia treatment trials will be discussed.   
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Table 1.  Demographic data for 22 subjects randomized to either 4 or 10 hours of aphasia 
treatment and 25 no-treatment control subjects with aphasia (includes mean, standard 
deviation and range) 
 
 4 hours / week 10 hours / week Control Group 
# Subjects 12 10 25 
Male:Female 9:3 5:5 16:9 
Age 55.57 (15.06) 
31.35  77.98 yrs 
56.54 (13.97) 
25.83  74.50 
58.2 (12.0) 
35.18  79.64 
Months post onset 
 
50.70 (45.84) 
7.3 - 159.8 
37.84 (26.26) 
7.6  77.3 
54.0 (59.3) 
12.2 - 253 
Baseline WAB AQ 48.76 (22.18) 
13.7  77.1 
49.59 (19.37) 
28.0  78.9 
53.74 (25.34) 
9.7  81.4 
 
 
Figure 1.  Examples of C-ORLA screens showing the animated agent.  The patient reads 
sentences aloud in unison with the animated agent and then independently.  Words are 
highlighted as the animated agent and patient read aloud together. 
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Figure 2.  Mean Change in WAB AQ Scores For Treatment Subjects Combined (N=22), 
No-Treatment Control Group (N=25),  and the 4-hour and 10 hour Treatment Groups 
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